Lipoprotein Lipase: Is It a Magic Target for the Treatment of Hypertriglyceridemia
High levels of triglycerides (TG) and triglyceride-rich lipoproteins (TGRLs) confer a residual risk of cardiovascular disease after optimal low-density lipoprotein cholesterol (LDL-C)–lowering therapy. Consensus has been made that LDL-C is a non-arguable primary target for lipid lowering treatment,...
| Váldodahkkit: | , , |
|---|---|
| Materiálatiipa: | Artihkal |
| Giella: | English |
| Almmustuhtton: |
Korean Endocrine Society
2022-08-01
|
| Ráidu: | Endocrinology and Metabolism |
| Fáttát: | |
| Liŋkkat: | http://www.e-enm.org/upload/pdf/enm-2022-402.pdf |